Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer

Metronomic chemotherapy has shown promising activity in numerous preclinical studies and also some phase II clinical studies involving various tumor types, and is currently undergoing phase III trial evaluation. Triple-negative breast cancer (TNBC) is an aggressive histological subtype with limited...

Descripción completa

Detalles Bibliográficos
Autores principales: Di Desidero, Teresa, Xu, Ping, Man, Shan, Bocci, Guido, Kerbel, Robert S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2015
Materias:
Priority Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767441/
https://www.ncbi.nlm.nih.gov/pubmed/26623560

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4767441/
https://www.ncbi.nlm.nih.gov/pubmed/26623560

Ejemplares similares